Healthcare demand outpacing investor expectations, boosting outlook for providers, Mizuho analysts say
Recent growth in inpatient and outpatient services has been even higher than elevated investor expectations, Mizuho Securities analysts said in a research note Tuesday. Outpatient volume grew 8% in the second quarter, compared with the year-earlier period, while inpatient volume grew 4%, according to a Mizuho survey of more than 200 doctors in 14 specialties. Last month, UnitedHealth Group Inc. (UNH) executives' comments on older adults catching up on surgeries delayed during the pandemic triggered a sharp selloff in health-insurance stocks. Noting the physician survey results and concerns about growth in outpatient Medicare utilization, the Mizuho analysts Tuesday cut their price targets on managed care companies Centene Corp. (CNC), Humana Inc. (HUM), and UnitedHealth Group, while raising price targets on shares of providers HCA Healthcare Inc. (HCA), Tenet Healthcare Corp. (THC), Universal Health Services Inc. (UHS) and Surgery Partners Inc. (SGRY).
-Eleanor Laise
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-11-23 0826ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
Baidu Earnings: Weakness In Advertising Offset by Continued Double-Digit Growth in Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?